Related Experiment Video

Updated: Aug 8, 2026

Assessment of DNA Double Strand Break Repair Activity Using High-throughput and Quantitative Luminescence-Based Reporter Assays
05:01

Assessment of DNA Double Strand Break Repair Activity Using High-throughput and Quantitative Luminescence-Based Reporter Assays

Published on: June 14, 2024

Emerging cancer therapeutic opportunities target DNA-repair systems

Jian Ding1, Ze-Hong Miao, Ling-Hua Meng

  • 1Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 201203, China. jding@mail.shcnc.ac.cn

Trends in Pharmacological Sciences
|May 16, 2006
PubMed

Insights

DNA-damaging agents are key in cancer therapy. Inhibiting tumor cell DNA repair can overcome drug resistance and improve treatment outcomes, with new targeted therapies in development.

Area of Science:

  • Oncology and Molecular Biology
  • Cancer Therapeutics
  • DNA Repair Mechanisms

Background:

  • DNA-damaging agents are crucial for non-surgical cancer treatment.
  • Therapeutic success depends on the balance between DNA damage and repair.
  • Enhanced DNA repair in tumors causes resistance to chemotherapy and radiation.

Purpose of the Study:

  • To highlight the role of DNA repair in cancer treatment efficacy.
  • To discuss the potential of targeting DNA repair pathways in combination therapy.
  • To review emerging small-molecule compounds targeting DNA repair systems.

Main Methods:

  • Literature review of DNA repair mechanisms in cancer.
  • Analysis of drug resistance associated with DNA repair capacity.
  • Survey of current clinical trials for DNA repair inhibitors.

Main Results:

  • Elevated DNA repair capacity in tumor cells confers resistance to DNA-damaging agents.
  • Interfering with DNA repair pathways is a promising strategy for combination cancer therapy.
  • Several small-molecule inhibitors targeting DNA repair are in clinical development.

Conclusions:

  • Targeting DNA repair is a viable strategy to enhance cancer treatment efficacy.
  • Overcoming drug resistance through DNA repair inhibition holds significant therapeutic potential.
  • Ongoing clinical trials are evaluating novel compounds for their anticancer effects by targeting DNA repair.

More Related Videos

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...